Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. [electronic resource]
Producer: 20170821Description: 128-135 p. digitalISSN:- 1879-355X
- Adenocarcinoma -- immunology
- Carcinoma, Squamous Cell -- immunology
- Chemoradiotherapy -- adverse effects
- Esophageal Neoplasms -- immunology
- Fluorouracil -- therapeutic use
- Humans
- Incidence
- Kaplan-Meier Estimate
- Lymphocyte Count
- Lymphopenia -- epidemiology
- Middle Aged
- Monocytes -- drug effects
- Neutrophils -- drug effects
- Odds Ratio
- Platinum Compounds -- therapeutic use
- Proportional Hazards Models
- Proton Therapy
- Radiotherapy Dosage
- Regression Analysis
- Retrospective Studies
- T-Lymphocytes -- drug effects
- Taxoids -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.